A nurse plans care for a client scheduled for a percutaneous needle biopsy of the kidney. Which actions should the nurse include in the plan of care? Select all that apply.

Rationale: A. Taking vital signs every 6 hours immediately after the procedure is insufficient. After a percutaneous kidney biopsy, vital signs should be monitored frequently—typically every 15–30 minutes for the first 1–2 hours, then hourly for several hours, to detect early signs of bleeding or hypotension. Waiting 6 hours between checks could delay identification of complications. B. Assessing the urine for hematuria is appropriate. Hematuria is a common complication after a kidney biopsy and may indicate bleeding. Early detection allows for prompt intervention, including fluid administration, monitoring, or notifying the healthcare provider. C. Assessing the biopsy site when obtaining vital signs is essential. The site should be checked for bleeding, swelling, or hematoma formation, as these are potential complications of a percutaneous kidney biopsy. This allows the nurse to identify local complications early. D. Assessing for foul-smelling urine three days after the procedure is not a priority nursing action immediately post-biopsy. While urinary tract infection is a possible complication, monitoring should focus on immediate signs of bleeding, pain, and vital signs in the first 24 hours. Three days post-procedure is outside the acute monitoring period. E. Performing a pain assessment when obtaining vital signs is important. Pain at the biopsy site or flank may indicate hematoma formation or internal bleeding, which requires immediate attention. Monitoring pain allows timely interventions such as analgesics and evaluation for complications.